Business · 19/12/2013
FDA and AAO Host Public Workshop on Developing Novel Endpoints for Premium Intraocular Lenses
The Food and Drug Administration (FDA) and the American Academy of Ophthalmology (AAO) are hosting a public workshop to discuss developing new endpoints for premium intraocular lenses. The workshop aims to explore innovative methods for evaluating the safety and effectiveness of these advanced lenses.
Original source language: Federal Register — Food and Drug AdministrationOpen original release →